Fibrinogen human Terminated Phase 2 Trials for Heart Valve Disease / Coronary Artery Disease (CAD) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01283321RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery